Chairman of the Board
Professor Thomas Szucs, MPH, LLM, MBA, has been the Chairman of the Board of Directors of the Helsana Group since 2010 and also serves in this function as Chairman of the Executive and Remuneration Committee, as well as Chairman of the Investment Committee and as a member of the Digitisation Committee.
Thomas D. Szucs is Professor and Director of the Institute for Pharmaceutical Medicine at the University of Basel, Switzerland. His research and teaching activity is focused on the areas of pharmacoeconomics, pharmaceuticals policy, healthcare provision research and healthcare technology assessment. He previously served as Head of Health Economics at the Institute of Social and Preventive Medicine of the University of Zurich. Positions he held in the past include the following: Head of Research and founder of the Pharmaeconomics Centre at the University of Milan, Italy; Head of the working group for clinical economics at the University of Munich, Germany; Senior Consultant at Arthur D. Little, Inc.; and Head of the Health Economics Department at Hoffmann-La Roche AG in Basel, Switzerland. Prof. Szucs is also a member of the editorial team of various specialist scientific journals.
After completing a medical degree and a doctorate at the University of Basel, Thomas Szucs attained a Master’s in Business Management from the University of St.Gallen, a Master of Public Health from Harvard University, an LL.M. in International Business Law from the University of Zurich and a doctorate in law from the Private University in the Principality of Liechtenstein. In 2010, he was named an honorary professor at Peking University’s Health Science Center. He is a specialist in pharmaceutical medicine, prevention and public health. He practises personalised medicine at the Klinik Hirslanden and helps to develop genomic medicine at the Hirslanden Group. Further activities, mandates:
We're here to help.